Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling

Mechanisms regulating glioma invasion

(2015) Ivy Paw et al.   CANCER LETTERS

WNT signaling in glioblastoma and therapeutic opportunities

(2015) Yeri Lee et al.   LABORATORY INVESTIGATION

Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9

(2015) Haiyu Zhang et al.   MOLECULAR CARCINOGENESIS

Immunohistochemical Study of Expression of Sohlh1 and Sohlh2 in Normal Adult Human Tissues

(2015) Xiaoli Zhang et al.   PLoS One

Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1

(2014) H. Zhang et al.   CARCINOGENESIS

Emerging Therapies for Glioblastoma

(2014) Alissa A. Thomas et al.   JAMA Neurology

Activation of canonical WNT/β-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition

(2012) Ulf D. Kahlert et al.   CANCER LETTERS

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Wnt/beta-Catenin Signaling in Glioma

(2012) Kailiang Zhang et al.   Journal of Neuroimmune Pharmacology

Glioblastoma survival in the United States before and during the temozolomide era

(2011) Derek R. Johnson et al.   JOURNAL OF NEURO-ONCOLOGY

Glycogen synthase kinase-3β regulates astrocytic differentiation of U87-MG human glioblastoma cells

(2010) Yan Li et al.   ACTA PHARMACOLOGICA SINICA

Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells

(2010) Xiao Yue et al.   BRAIN RESEARCH

Survival analysis of 205 patients with glioblastoma multiforme: Clinical characteristics, treatment and prognosis in China

(2009) Xiangyu Ma et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas

(2009) Gangadhara Reddy Sareddy et al.   NEUROCHEMISTRY INTERNATIONAL